Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.76 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.76 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.76 |
| ▸ | CNR2 | P34972 | 3/20 | 0.71 |
| ▸ | CNR1 | P21554 | 2/20 | 0.71 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.71 |
| ▸ | PPARG | P37231 | 2/20 | 0.71 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.71 |
| ▸ | INHA | P05111 | 1/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.71 |
| ▸ | HTR2A | P28223 | 1/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.71 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.71 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.71 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.71 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.71 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.71 |
| ▸ | PTGES | O14684 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24596011 | 0.93 | SLC6A3 (0.76) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL24233347 | 0.90 | SLC6A3 (0.72) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL27206293 | 0.90 | SLC6A3 (0.72) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL22778046 | 0.89 | SLC6A3 (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL30117365 | 0.89 | SLC6A3 (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL22778048 | 0.89 | SLC6A3 (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL16212552 | 0.88 | CYP19A1 (0.68) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL31545439 | 0.88 | PPARG (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL23537655 | 0.88 | PPARG (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 | |
| SCHEMBL706787 | 0.88 | PPARG (0.71) | SLC6A3TRPM7DAGLACNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2023-04-13 | — | — | US | disclosed |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-09 | — | — | US | disclosed |
| WO-2021237371-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-02 | — | — | WO | disclosed |
| US-20210276936-A1 | Synthesis of Cannabigerol | TREEHOUSE BIOTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| US-11040932-B2 | Synthesis of cannabigerol | TREEHOUSE BIOTECH, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| WO-2020249184-A1 | SYNTHESIS AND PURIFICATION OF CANNABIGEROL AND ITS APPLICATION | SYMRISE AG (DE) | 2020-12-17 | — | — | WO | disclosed |
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | TREEHOUSE BIOTECH, INC. | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | SLC6A3 3217/4885TRPM7 4203/4885DAGLA 617/4885 |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | SLC6A3 3217/4885TRPM7 4203/4885DAGLA 617/4885 |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | ADH1A, ADH1C, AHR | SLC6A3 3217/4885TRPM7 4203/4885DAGLA 617/4885 |
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | COASY, ACSL3, SQLE | SLC6A3 3503/4885TRPM7 3181/4885DAGLA 77/4885 |
| US-11040932-B2 | Synthesis of cannabigerol | COASY, ACSL3, SQLE | SLC6A3 3503/4885TRPM7 3181/4885DAGLA 77/4885 |
| US-20210276936-A1 | Synthesis of Cannabigerol | COASY, ACSL3, SQLE | SLC6A3 3503/4885TRPM7 3181/4885DAGLA 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.